This newsletter is designed to give you a quick, monthly update on news and events about the Virginia BioTechnology Research Park, www.vabiotech.com, its tenants and biosciences in Central Virginia. We hope you find it useful and share it with your colleagues. If you would prefer to be removed from the distribution list, click here to unsubscribe.

BIOTECH PARK NEWS

AWARDS, HONORS AND GRANTS

• VCU critical injury and illness research group lands $3.5 million in grants for research using blood substitute

RESEARCH @ VCU

• VCU web study targets preventive care
• Researchers identify how herpes virus infects host cell
• Minimally invasive technique may offer quick and safe pain relief in osteoporosis patients with low back pain
• PET scans found to significantly impact treatment decisions made by clinicians

BIOTECH PARK NEWS

EnzySurge, maker of DermaStream™, establishes a U.S. office in the Virginia Biosciences Commercialization Center
The Virginia Biosciences Commercialization Center (VBCC) recently welcomed EnzySurge, an israeli bioscience company focused on chronic wound management, as the newest member of the VBCC program.
More info

Park's Commercialization Center welcomes BioProtect
The Virginia Biosciences Commercialization Center recently announced the newest company to establish their U.S. office and join the VBCC program -- BioProtect, a bioscience company focused on development of a medical device that increases the effectiveness of radiation therapy.
More info

Commercialization Center company to partner with VCU Massey Cancer Center on $1M pancreatic cancer clinical research study
Virginia Commonwealth University Massey Cancer Center will open a Phase I pancreatic cancer study later this year in conjunction with leading researchers from Israel, marking the first time cancer researchers at VCU have partnered with their counterparts in Israel.
More info

AWARDS, HONORS AND GRANTS

VCU critical injury and illness research group lands $3.5 million in grants for research using blood substitute
The Office of Naval Research awarded $3.5 million in four grants to the Virginia Commonwealth University Reanimation Engineering Shock Center, VCURES, for research using the blood substitute Oxycyte in studies of decompression sickness, embolisms, traumatic brain injury and blast injuries.
More info

RESEARCH@VCU

VCU Web study targets preventive care
Patients in a Virginia Commonwealth University project using a Web-based system that interacts with their medical records may find their doctors offering more preventive health services.
More info

Researchers identify how herpes virus infects host cells
Virginia Commonwealth University researchers have uncovered new information about how the herpes simplex virus takes control of the host cell, setting the stage for the development of antiviral drugs that serve to fight herpes infections.
More info

Minimally invasive technique may offer quick and safe pain relief in osteoporosis patients with low back pain
An X-ray guided injection of synthetic bone cement into fractured pelvic bones may provide rapid and safe pain relief to osteoporosis patients with low back pain, according to a new multicenter pilot study.
More info

PET scans found to significantly impact treatment decisions made by clinicians
Clinicians using positron emission tomography scan results in cancer detection changed their treatment decision in more than one third of patient cases, according to a national study led by a Virginia Commonwealth University physician.
More info